Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Vorchheimer

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Family Practice|June 9, 2005
What is QT interval prolongation?David A Vorchheimer
Mayo Clinic Proceedings|January 28, 2006
Platelets in atherothrombosisDavid A Vorchheimer, Richard Becker
Journal of Thrombosis and Thrombolysis|July 28, 2004
Multi-bed vascular disease and atherothrombosis: scope of the problemWilliam Lane Duvall, David A Vorchheimer
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 22, 2016
Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalizationDaniele Massera, Dan Wang, David A Vorchheimer, et al.
The American Journal of Hospice & Palliative Care|April 22, 2022
Exploring the Changes in Code Status During the COVID-19 Pandemic and the Implications for Future Pandemic CareAdarsh Katamreddy, Alexander M Ye, David A Vorchheimer, et al.
Vascular Medicine (London, England)|October 8, 2009
Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 monthsRobert A Lookstein, Adam D Talenfeld, Roman Raju, et al.
Chest|September 24, 2004
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyRobert A Harrington, Richard C Becker, Michael Ezekowitz, et al.
Thrombosis and Haemostasis|January 12, 2010
A new oral antiplatelet agent with potent antithrombotic properties: comparison of DZ-697b with clopidogrel a randomised phase I studyM Urooj Zafar, Borja Ibáñez, Brian G Choi, et al.
Thrombosis and Haemostasis|October 17, 2007
Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamberMohammad Urooj Zafar, David A Vorchheimer, Juan Gaztanaga, et al.
Thrombosis and Haemostasis|August 9, 2014
Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudinM Urooj Zafar, David A Vorchheimer, Mita Patel Tewar, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Family Practice|June 9, 2005
What is QT interval prolongation?David A Vorchheimer
Mayo Clinic Proceedings|January 28, 2006
Platelets in atherothrombosisDavid A Vorchheimer, Richard Becker
Journal of Thrombosis and Thrombolysis|July 28, 2004
Multi-bed vascular disease and atherothrombosis: scope of the problemWilliam Lane Duvall, David A Vorchheimer
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 22, 2016
Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalizationDaniele Massera, Dan Wang, David A Vorchheimer, et al.
The American Journal of Hospice & Palliative Care|April 22, 2022
Exploring the Changes in Code Status During the COVID-19 Pandemic and the Implications for Future Pandemic CareAdarsh Katamreddy, Alexander M Ye, David A Vorchheimer, et al.
Vascular Medicine (London, England)|October 8, 2009
Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 monthsRobert A Lookstein, Adam D Talenfeld, Roman Raju, et al.
Chest|September 24, 2004
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyRobert A Harrington, Richard C Becker, Michael Ezekowitz, et al.
Thrombosis and Haemostasis|January 12, 2010
A new oral antiplatelet agent with potent antithrombotic properties: comparison of DZ-697b with clopidogrel a randomised phase I studyM Urooj Zafar, Borja Ibáñez, Brian G Choi, et al.
Thrombosis and Haemostasis|October 17, 2007
Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamberMohammad Urooj Zafar, David A Vorchheimer, Juan Gaztanaga, et al.
Thrombosis and Haemostasis|August 9, 2014
Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudinM Urooj Zafar, David A Vorchheimer, Mita Patel Tewar, et al.
Pageof 2